Mohammad Jurri, MD
Family Medicine · North Bergen, NJNPI 1467089078
Payments from drug & device makers
Across 78 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intra-sana Laboratories$266
- AstraZeneca$231
- Novo Nordisk$210
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$195
- Lilly USA, LLC$109
- Pfizer$68
- plus $387 from 15 others
What the payments were for
- Food & beverage$1,466100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intra-sana Laboratories | 9 | $266 |
| AstraZeneca | 13 | $231 |
| Novo Nordisk | 11 | $210 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $195 |
| Lilly USA, LLC | 7 | $109 |
| Pfizer | 4 | $68 |
| Optinose US, Inc. | 3 | $52 |
| Currax Pharmaceuticals LLC | 3 | $51 |
| Exact Sciences | 2 | $45 |
| Gilead | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| Azurity Pharmaceuticals, Inc. | 2 | $29 |
| Echosens North America, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $18 |
| Cleerly, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Biogen | 1 | $15 |
| Merck | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GLYCATE$150
- Reltone 400 Mg$150
- Reltone 200 Mg$150
How this compares
$1,466 in reported general payments places this provider in the 70th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 51 | $197 |
| Promethazine Hcl | 25 | $168 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $160 |
| Fluticasone Propionate | 13 | $126 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $116 |
| Losartan Potassium | 14 | $114 |
| Levocetirizine Dihydrochloride | 28 | $110 |
| Cyclobenzaprine Hcl | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Other family medicine in North Bergen
- Jonathan DominguezNorth Bergen$30K
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.